These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 8446178

  • 1. Growth inhibition of human colon adenocarcinoma-derived Caco-2 cells by 1,25-dihydroxyvitamin D3 and two synthetic analogs: relation to in vitro hypercalcemic potential.
    Cross HS, Farsoudi KH, Peterlik M.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):105-10. PubMed ID: 8446178
    [Abstract] [Full Text] [Related]

  • 2. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
    Jung SJ, Lee YY, Pakkala S, de Vos S, Elstner E, Norman AW, Green J, Uskokovic M, Koeffler HP.
    Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
    [Abstract] [Full Text] [Related]

  • 3. Antiproliferative effect of 1,25-dihydroxyvitamin D3 and its analogs on human colon adenocarcinoma cells (CaCo-2): influence of extracellular calcium.
    Cross HS, Huber C, Peterlik M.
    Biochem Biophys Res Commun; 1991 Aug 30; 179(1):57-62. PubMed ID: 1883380
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.
    Pakkala S, de Vos S, Elstner E, Rude RK, Uskokovic M, Binderup L, Koeffler HP.
    Leuk Res; 1995 Jan 30; 19(1):65-72. PubMed ID: 7837819
    [Abstract] [Full Text] [Related]

  • 5. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
    Bischof MG, Redlich K, Schiller C, Chirayath MV, Uskokovic M, Peterlik M, Cross HS.
    J Pharmacol Exp Ther; 1995 Dec 30; 275(3):1254-60. PubMed ID: 8531089
    [Abstract] [Full Text] [Related]

  • 6. Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization.
    Zhou JY, Norman AW, Lübbert M, Collins ED, Uskokovic MR, Koeffler HP.
    Blood; 1989 Jul 30; 74(1):82-93. PubMed ID: 2665845
    [Abstract] [Full Text] [Related]

  • 7. Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines.
    de Vos S, Holden S, Heber D, Elstner E, Binderup L, Uskokovic M, Rude B, Chen DL, Le J, Cho SK, Koeffler HP.
    Prostate; 1997 May 01; 31(2):77-83. PubMed ID: 9140119
    [Abstract] [Full Text] [Related]

  • 8. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y, Pike JW, Koeffler HP.
    Leuk Res; 1995 Mar 01; 19(3):147-58. PubMed ID: 7700077
    [Abstract] [Full Text] [Related]

  • 9. Effects of 1alpha,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-beta estradiol.
    Rao LG, Sutherland MK, Reddy GS, Siu-Caldera ML, Uskokovic MR, Murray TM.
    Bone; 1996 Dec 01; 19(6):621-7. PubMed ID: 8968029
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity.
    Bouillon R, Allewaert K, Xiang DZ, Tan BK, van Baelen H.
    J Bone Miner Res; 1991 Oct 01; 6(10):1051-7. PubMed ID: 1796753
    [Abstract] [Full Text] [Related]

  • 11. Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism.
    Zhou JY, Norman AW, Akashi M, Chen DL, Uskokovic MR, Aurrecoechea JM, Dauben WG, Okamura WH, Koeffler HP.
    Blood; 1991 Jul 01; 78(1):75-82. PubMed ID: 1648977
    [Abstract] [Full Text] [Related]

  • 12. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668
    [Abstract] [Full Text] [Related]

  • 13. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW, Sergeev IN, Bishop JE, Okamura WH.
    Cancer Res; 1993 Sep 01; 53(17):3935-42. PubMed ID: 8395333
    [Abstract] [Full Text] [Related]

  • 14. 1,25-(OH)2-16ene-23yne-D3 reduces secondary hyperparathyroidism in uremic rats with little calcemic effect.
    Lippuner K, Perrelet R, Casez JP, Popp A, Uskokovic MR, Jaeger P.
    Horm Res; 2004 Sep 01; 61(1):7-16. PubMed ID: 14646396
    [Abstract] [Full Text] [Related]

  • 15. Growth control of human colon-adenocarcinoma-derived Caco-2 cells by vitamin-D compounds and extracellular calcium in vitro: relation to c-myc-oncogene and vitamin-D-receptor expression.
    Hulla W, Kállay E, Krugluger W, Peterlik M, Cross HS.
    Int J Cancer; 1995 Sep 15; 62(6):711-6. PubMed ID: 7558419
    [Abstract] [Full Text] [Related]

  • 16. Effects of two new vitamin D3 derivatives, 22-oxa-1 alpha-25-dihydroxyvitamin D3 (OCT) and 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3 (ED-71), on bone metabolism in organ culture.
    Sato K, Nishii Y, Woodiel FN, Raisz LG.
    Bone; 1993 Sep 15; 14(1):47-51. PubMed ID: 8443002
    [Abstract] [Full Text] [Related]

  • 17. Variation in 1,25-dihydroxyvitamin D3 regulation of proliferation and alkaline phosphatase activity in late-passage rat osteoblastic cell lines.
    Murray S, Glackin C, Murray E.
    J Steroid Biochem Mol Biol; 1993 Aug 15; 46(2):227-33. PubMed ID: 8664171
    [Abstract] [Full Text] [Related]

  • 18. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW, Zhou JY, Henry HL, Uskokovic MR, Koeffler HP.
    Cancer Res; 1990 Nov 01; 50(21):6857-64. PubMed ID: 2208153
    [Abstract] [Full Text] [Related]

  • 19. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ, Peehl DM, Feldman D.
    Endocrinology; 1995 Jan 01; 136(1):20-6. PubMed ID: 7530193
    [Abstract] [Full Text] [Related]

  • 20. Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner.
    Svendsen ML, Daneels G, Geysen J, Binderup L, Kragballe K.
    Pharmacol Toxicol; 1997 Jan 01; 80(1):49-56. PubMed ID: 9148283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.